查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423580

到 2030 年 DNA 微陣列市場預測：按類型、技術、應用、最終用戶和地區分類的全球分析

DNA Microarray Market Forecasts to 2030 - Global Analysis By Type (Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA) and Other Types), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球 DNA 微陣列市場規模將達到 37 億美元，預計到 2030 年將達到 76 億美元，預測期內複合年成長率為 10.7%。

DNA 微陣列是分子生物學中使用的強大工具，可在一次實驗中同時分析數千個基因的表現量。 DNA 微陣列是包含 DNA 探針的微觀斑點陣列，每個斑點代表一個特定的基因或基因片段。透過將螢光標記的 DNA 或 RNA 樣本與這些點雜交，科學家可以檢測和測量給定樣本中數千個基因的表達水平，使科學家能夠確定基因功能、調控，深入了解生物系統內的相互作用。這項技術在基因組學、遺傳學和生物醫學研究等領域至關重要。

加拿大癌症協會估計，加拿大已報告 233,900 例新癌症病例和 85,100 例死亡。

基因組學研究進展

DNA 微陣列市場的基因組學研究取得了重大進展，徹底改變了個人化醫療和疾病理解。微陣列技術的創新將推動基因表現、突變分析和基因組變異的研究。改進的生物資訊學工具簡化了資料分析並能夠全面洞察複雜的生物系統。這些進步將促進臨床診斷、藥物研發和生物標記識別的應用，為精準醫學和標靶治療鋪平道路。

道德和隱私問題

DNA 微陣列引起了倫理問題，因為遺傳資料可能被濫用，引發隱私、同意和歧視問題。收集的大量資料可能會被濫用，在未經知情同意的情況下使敏感的個人資訊面臨風險。此外，人們還擔心結果的準確性和解釋，這可能會因不確定或誤解的遺傳資料而影響個人的生活。這些都是限制該產業發展的因素。

個人化醫療需求不斷成長

由於對個人化醫療的興趣日益濃厚，市場需求激增。這一趨勢是由能夠快速準確地分析個人遺傳傾向和量身定做治療計劃的技術所推動的。隨著醫療保健轉向精準醫療，這些微陣列在深入了解基因突變、支持標靶治療和改善患者治療效果方面發揮著至關重要的作用。這種不斷成長的需求證實了它在推動個人化醫療保健解決方案方面發揮的關鍵作用。

高成本

由於需要複雜的製造流程、專業設備和精確的品管措施，市場歷來面臨高成本。這些因素導致原物料成本、研發成本和生產成本急劇上升。此外，技術的複雜性以及對準確性和可靠性的要求進一步推高了成本，使得微陣列用於研究和診斷目的的投資昂貴。

COVID-19 的影響：

COVID-19大流行引起了DNA微陣列市場的波動。最初，供應鏈中斷和實驗室關閉導致市場放緩。然而，對診斷和研究目的的需求不斷增加以及個人化醫療的進步促進了市場的成長。遠距工作和資料分析技術的快速創新和適應也對市場產生了積極影響。總體而言，疫情造成了波動，但最終加速了技術進步和應用市場拓展。

藥物基因體學領域預計在預測期內將是最大的

預計藥物基因體學領域在預測期內將是最大的領域。此領域利用 DNA 微陣列來識別影響藥物代謝、功效和副作用的遺傳變異，從而實現個人化治療方法。該行業的成長是由精準醫療的需求推動的，精準醫療的目標是實現量身定做的藥物選擇和管理，以改善患者的治療效果，從而實現個性化的治療性介入。它在護理行業中發揮著至關重要的作用。

預計診斷中心產業在預測期內複合年成長率最高

診斷中心領域預計在預測期內複合年成長率最高。這些中心使用微陣列同時檢查大量基因，以識別與疾病相關的突變。微陣列平台的進步提高了準確性和通量，促進快速診斷和個人化治療策略。這種市場區隔在解讀遺傳訊息、推動標靶治療和精準醫療介入的創新方面發揮關鍵作用。

比最大的地區

預計北美在預測期內將佔據最大的市場佔有率。該地區的市場成長是由基因組學、個人化醫療和生物技術投資不斷增加所推動的。擴大採用先進醫療技術、策略聯盟和支持性法規環境等因素正在促進市場擴張，滿足研究、診斷和製藥業的多樣化應用。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。該地區市場對個人化醫療、基因研究和診斷的需求不斷成長，推動了市場擴張。主要企業、策略聯盟和政府對基因組學研究的支持正在促進市場的穩定成長。此外，醫療保健專業人員和研究人員對基因組技術的認知和採用的提高也推動了該地區的市場擴張。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球 DNA 微陣列市場：依類型

  • 寡核苷酸 DNA 微陣列 (oDNA)
  • 互補 DNA 微陣列 (cDNA)
  • 其他類型

第6章全球 DNA 微陣列市場：依技術分類

  • 噴墨
  • 微流體學
  • 雜合反應
  • 其他技術

第7章全球DNA 微陣列市場：依應用分類

  • 藥物基因組學
  • 基因表現分析
  • 癌症研究
  • 基因型鑒定
  • 蛋白質體學
  • 毒理基因組學
  • 遺傳學
  • 藥物研發
  • 法醫調查
  • 神經科學
  • 其他用途

第8章全球DNA 微陣列市場：依最終使用者分類

  • 受託研究機構（CRO）
  • 生技公司
  • 醫院和診所
  • 學術研究所
  • 診斷中心
  • 其他最終用戶

第9章全球 DNA 微陣列市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Applied Micro Arrays
  • Illumina, Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • PerkinElmer
  • Oxford Gene Technology（OGT）
  • Arrayit Corporation
  • Roche NimbleGen
  • Savyon Diagnostics
  • WaferGen Biosystems
  • Novacyt Group
  • Enzo Biochem, Inc.
Product Code: SMRC24814

According to Stratistics MRC, the Global DNA Microarray Market is accounted for $3.7 billion in 2023 and is expected to reach $7.6 billion by 2030 growing at a CAGR of 10.7% during the forecast period. A DNA microarray is a powerful tool used in molecular biology to simultaneously analyze the expression levels of thousands of genes in a single experiment. It consists of an arrayed series of microscopic spots containing DNA probes, each spot representing a specific gene or fragment of a gene. By hybridizing fluorescently labelled DNA or RNA samples onto these spots, scientists can detect and measure the expression levels of thousands of genes in a given sample, providing insights into gene function, regulation, and interactions within biological systems. This technology has been pivotal in fields like genomics, genetics, and biomedical research.

According to estimates by the Canadian Cancer Society, the country reported 233,900 new cancer cases with 85,100 deaths.

Market Dynamics:

Driver:

Advancements in genomics research

Genomics research within the DNA Microarray market has witnessed substantial advancements, revolutionizing personalized medicine and disease understanding. Innovations in microarray technology propel research in gene expression, mutation analysis, and genomic variations. Improved bioinformatics tools streamline data analysis, enabling comprehensive insights into complex biological systems. These advancements foster applications in clinical diagnostics, drug discovery, and biomarker identification, paving the way for precision medicine and targeted therapies.

Restraint:

Ethical and privacy concerns

DNA Microarrays pose ethical concerns due to potential misuse of genetic data, raising issues of privacy infringement, consent, and discrimination. The vast data collected can be exploited, compromising individuals' sensitive information without their informed consent. Additionally, concerns arise regarding the accuracy and interpretation of results, potentially impacting individuals' lives based on uncertain or misinterpreted genetic data. These are the factors restraining the growth of the segment.

Opportunity:

Rising demand for personalized medicine

The market is witnessing a surge in demand due to the growing interest in personalized medicine. This trend is fuelled by the technology's ability to analyze an individual's genetic makeup swiftly and accurately, enabling tailored treatment plans. As healthcare shifts toward precision medicine, these microarrays play a pivotal role by offering insights into genetic variations, aiding in targeted therapies, and enhancing patient outcomes. This rising demand underscores the pivotal role in advancing personalized healthcare solutions.

Threat:

High costs

The market has historically faced high costs due to intricate manufacturing processes, specialized equipment, and the need for precise quality control measures. These factors contribute to elevated expenses in raw materials, research, development, and production. Additionally, the complexity of the technology and the demand for accuracy and reliability further drives up costs, making microarrays a costly investment for research and diagnostic purposes.

Covid-19 Impact:

The COVID-19 pandemic triggered fluctuations in the DNA Microarray market. Initially, disruptions in supply chains and lab closures led to a slowdown. However, increased demand for diagnostics and research purposes, along with advancements in personalized medicine, boosted market growth. Rapid innovation and adaptation in technology for remote work and data analysis also influenced the market positively. Overall, the pandemic caused fluctuations but ultimately accelerated technological advancements and market expansion in applications.

The Pharmacogenomics segment is expected to be the largest during the forecast period

The pharmacogenomics segment is expected to be the largest during the forecast period. This segment utilizes DNA microarrays to identify genetic variations influencing drug metabolism, efficacy, and adverse reactions, guiding personalized treatment approaches. Its growth is driven by the demand for precision medicine, enabling tailored drug selection and dosing for better patient outcomes, making it a pivotal player in the healthcare industry's quest for personalized therapeutic interventions.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

The diagnostic centers segment is expected to have the highest CAGR during the forecast period. These centers employ microarrays to simultaneously examine numerous genes, identifying variations linked to illnesses. Advancements in microarray platforms enhance precision and throughput, fostering quicker diagnoses and personalized treatment strategies. This market segment thrives due to its pivotal role in decoding genetic information, driving innovation for targeted therapies and precise medical interventions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region's market growth is propelled by rising investments in genomics, personalized medicine, and biotechnology. Factors such as increased adoption of advanced healthcare technologies, strategic collaborations, and a supportive regulatory environment contribute to the market's expansion, catering to diverse applications across research, diagnostics, and pharmaceutical industries.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The region's market witnesses escalating demand for personalized medicine, genetic research, and diagnostics, fostering market expansion. Key players, strategic collaborations, and government support for genomics research contribute to the market's steady rise. Moreover, growing awareness and adoption of genomic technologies among healthcare professionals and researchers further fuel the market's evolution in the region.

Key players in the market

Some of the key players in DNA Microarray market include Applied Micro Arrays, Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, PerkinElmer, Oxford Gene Technology (OGT), Arrayit Corporation, Roche NimbleGen, Savyon Diagnostics, WaferGen Biosystems, Novacyt Group and Enzo Biochem, Inc.

Key Developments:

In August 2022, Thermo Fisher Scientific launched a new chromosomal microarray, the Applied Biosystem CytoScan HD Accel array, to improve cytogenetic research lab productivity, efficiency, and profitability with two-day turnaround time. This strategy helped the company to expand their product portfolio.

In May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar.

Types Covered:

  • Oligonucleotide DNA Microarrays (oDNA)
  • Complementary DNA Microarrays (cDNA)
  • Other Types

Technologies Covered:

  • Inkjet
  • Microfluidics
  • Hybridization
  • Other Technologies

Applications Covered:

  • Gene Expression Analysis
  • Cancer Research
  • Genotyping
  • Genetics
  • Drug Discovery
  • Forensic Science
  • Neuroscience
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Research Institutes
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global DNA Microarray Market, By Type

  • 5.1 Introduction
  • 5.2 Oligonucleotide DNA Microarrays (oDNA)
  • 5.3 Complementary DNA Microarrays (cDNA)
  • 5.4 Other Types

6 Global DNA Microarray Market, By Technology

  • 6.1 Introduction
  • 6.2 Inkjet
  • 6.3 Microfluidics
  • 6.4 Hybridization
  • 6.5 Other Technologies

7 Global DNA Microarray Market, By Application

  • 7.1 Introduction
  • 7.2 Pharmacogenomics
  • 7.3 Gene Expression Analysis
  • 7.4 Cancer Research
  • 7.5 Genotyping
  • 7.6 Proteomics
  • 7.7 Toxicogenomics
  • 7.8 Genetics
  • 7.9 Drug Discovery
  • 7.10 Forensic Science
  • 7.11 Neuroscience
  • 7.12 Other Applications

8 Global DNA Microarray Market, By End User

  • 8.1 Introduction
  • 8.2 Contract Research Organizations (CROs)
  • 8.3 Biotechnology Companies
  • 8.4 Hospitals and Clinics
  • 8.5 Academic and Research Institutes
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global DNA Microarray Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Applied Micro Arrays
  • 11.2 Illumina, Inc.
  • 11.3 QIAGEN
  • 11.4 F. Hoffmann-La Roche Ltd.
  • 11.5 Thermo Fisher Scientific, Inc.
  • 11.6 PerkinElmer, Inc.
  • 11.7 Merck KGaA
  • 11.8 Agilent Technologies, Inc.
  • 11.9 Bio-Rad Laboratories
  • 11.10 PerkinElmer
  • 11.11 Oxford Gene Technology (OGT)
  • 11.12 Arrayit Corporation
  • 11.11 Roche NimbleGen
  • 11.14 Savyon Diagnostics
  • 11.15 WaferGen Biosystems
  • 11.16 Novacyt Group
  • 11.17 Enzo Biochem, Inc.

List of Tables

  • Table 1 Global DNA Microarray Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global DNA Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global DNA Microarray Market Outlook, By Oligonucleotide DNA Microarrays (oDNA) (2021-2030) ($MN)
  • Table 4 Global DNA Microarray Market Outlook, By Complementary DNA Microarrays (cDNA) (2021-2030) ($MN)
  • Table 5 Global DNA Microarray Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global DNA Microarray Market Outlook, By Technology (2021-2030) ($MN)
  • Table 7 Global DNA Microarray Market Outlook, By Inkjet (2021-2030) ($MN)
  • Table 8 Global DNA Microarray Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 9 Global DNA Microarray Market Outlook, By Hybridization (2021-2030) ($MN)
  • Table 10 Global DNA Microarray Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 11 Global DNA Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global DNA Microarray Market Outlook, By Gene Expression Analysis (2021-2030) ($MN)
  • Table 13 Global DNA Microarray Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 14 Global DNA Microarray Market Outlook, By Genotyping (2021-2030) ($MN)
  • Table 15 Global DNA Microarray Market Outlook, By Genetics (2021-2030) ($MN)
  • Table 16 Global DNA Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 17 Global DNA Microarray Market Outlook, By Forensic Science (2021-2030) ($MN)
  • Table 18 Global DNA Microarray Market Outlook, By Neuroscience (2021-2030) ($MN)
  • Table 19 Global DNA Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 20 Global DNA Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global DNA Microarray Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 22 Global DNA Microarray Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 23 Global DNA Microarray Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 24 Global DNA Microarray Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 25 Global DNA Microarray Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 26 Global DNA Microarray Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.